Showing results (101-110 of 185) with videos related to
Sort By:
Pageof 19
Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
Signal transduction inhibitors in the treatment of breast cancerRita Nahta, Gabriel N Hortobagyi, Francisco J EstevaCurrent Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
The BCL2-family of protein ligands as cancer drugs: the next generation of therapeuticsWenJing Liu, Anca Bulgaru, Missak Haigentz, et al.Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
Pharmacogenetics of irinotecanG Toffoli, E Cecchin, G Corona, et al.Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agentsS Theocharisa, A Margeli, G KouraklisCurrent Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Signal transduction inhibitors as radiosensitizersA Tenzer, D Zingg, O Riesterer, et al.Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
The 'other' telomerase inhibitors: non-G-quadruplex interactive agent, non-antisense, non-reverse transcriptase telomerase inhibitorsL A BeltzCurrent Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
How to inhibit telomerase activity for cancer therapySatoru Kyo, Masaki InoueCurrent Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Cross-talk between cellular stress, cell cycle and anticancer agents: mechanistic aspectsE Tiligada, V Miligkos, A DelitheosCurrent Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Porphyrins in photodynamic therapy - a search for ideal photosensitizersS K Pushpan, S Venkatraman, V G Anand, et al.Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Herbal medicine in the treatment of cancerJohn W Ho, Yuet Kin Leung, Chun Pong ChanPageof 19